胺C2应用对人类喉癌细胞的影响:细胞培养研究
O Oğuz1, F Manole, N Bayar Muluk
1Department of Audiology, Istanbul Nişantaşı University, Health Services Vocational School, Istanbul, Turkey. nbayarmuluk@yahoo.com.
European review for medical and pharmacological sciences
|October 23, 2023
概括
短链胺C2对人类喉癌细胞表现出显著的细胞毒性,以剂量和时间依赖的方式降低活力并诱导亡. 这表明陶化物C2
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 人类喉癌是一个重大的健康问题.
- 了解癌细胞死亡的分子机制对于开发有效的治疗方法至关重要.
- 胺是生物活性脂质,在细胞信号传递和细胞亡中具有已知的作用.
研究的目的:
- 研究短链胺C2对人类喉癌HEp-2细胞的细胞毒和亡作用.
- 评估胺C2对细胞活力,细胞亡,酶激活和细胞迁移的影响.
主要方法:
- 人类喉表皮癌HEp-2细胞被用不同度的C2陶 (3.13100μM) 治疗了24小时和48小时.
- 用MTT测定来评估细胞毒性.
- 通过Annexin-V染色和流细胞计分析了亡.
- 通过流细胞计测量测量了-3/7激活.
- 使用共聚焦显微镜观察到形态变化.
- 用伤口愈合试验评估细胞迁移.
主要成果:
- 胺C2显著降低了HEp-2细胞活力,以剂量和时间依赖的方式,在100μM的最大抑制为24小时.
- 胺C2诱导HEp-2细胞的亡,与对照组相比,大约61.40%的细胞表现出亡症状.
- 观察到卡斯巴-3/7激活和特征性的亡形态变化.
- 胺C2显著抑制了HEp-2细胞的迁移和增殖.
结论:
- 短链胺C2在人类喉癌细胞上表现出强烈的细胞毒性和前性作用.
- 观察到的效应是通过酶依赖的亡中介的,可能是由于细胞内胺水平升高.
- 胺C2显示出开发用于喉癌的新型抗癌疗法的候选人潜力,需要进一步的体外和体内研究.
更多相关视频
07:33Lipid Vesicle-mediated Affinity Chromatography using Magnetic Activated Cell Sorting LIMACS: a Novel Method to Analyze Protein-lipid Interaction
Published on: April 26, 2011
12.6K
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
